UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 39

Sortiert nach

O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A8-A8

2024

Volltextzugriff (PDF)

Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain

Reumatologia clinica, 2016-09, Vol.12 (5), p.256-262

2016

Volltextzugriff (PDF)

Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department

Reumatologia clinica, 2017-05, Vol.13 (3), p.150

2017

Volltextzugriff (PDF)

Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

Rheumatology (Oxford, England), 2024-01, Vol.63 (1), p.72-78

2024

Volltextzugriff (PDF)

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Rheumatology (Oxford, England), 2021-11, Vol.60 (11), p.5329-5336

2021

Volltextzugriff (PDF)

Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

Seminars in arthritis and rheumatism, 2023-02, Vol.58, p.152121-152121, Article 152121

2023

Volltextzugriff (PDF)

Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

Seminars in arthritis and rheumatism, 2022-02, Vol.52, p.151946-151946, Article 151946

2022

Volltextzugriff (PDF)

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

Lupus science & medicine, 2024-04, Vol.11 (1), p.e001096

2024

Volltextzugriff (PDF)

P129 Does the perspective of SLE patients match the expert opinion and definitions of remission and low disease activity state? Prospective analysis of 500 patients from a Spanish multicenter cohort

Lupus science & medicine, 2024-03, Vol.11 (Suppl 1), p.A134-A135

2024

Volltextzugriff (PDF)

Steroid therapy in clinically stable but serologically active systemic lupus erythematosus prevents severe disease flares

Expert review of clinical immunology, 2007-05, Vol.3 (3), p.267-269

2007

Volltextzugriff (PDF)

68 years old woman with right leg weakness and colostasis

Reumatologia clinica, 2011-05, Vol.7 (3), p.208

2011

Volltextzugriff (PDF)

Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

Seminars in arthritis and rheumatism, 2015-06, Vol.44 (6), p.618-626

2015

Volltextzugriff (PDF)

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

Respiratory medicine, 2021-02, Vol.177, p.106241-106241, Article 106241

2021

Volltextzugriff (PDF)

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus

Clinical and experimental rheumatology, 2016-03, Vol.34 (2 Suppl 96), p.S40

2016

Volltextzugriff (PDF)

Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study

Arthritis research & therapy, 2015-08, Vol.17 (1), p.211-211, Article 211

2015

Volltextzugriff (PDF)

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

Lupus science & medicine, 2024-08, Vol.11 (2), p.e001064

2024

Volltextzugriff (PDF)

Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

Rheumatic & musculoskeletal diseases open, 2024-04, Vol.10 (2), p.e004207

2024

Volltextzugriff (PDF)

Health Related Quality of Life in Rheumatoid Arthritis, Osteoarthritis, Diabetes Mellitus, End Stage Renal Disease and Geriatric Subjects. Experience From a General Hospital in Mexico

Reumatología clinica (Barcelona), 2015-03, Vol.11 (2), p.68-72

2015

Volltextzugriff (PDF)

P149 Association between geographic and climatological conditions and cutaneous manifestations in lupus patients from the Spanish rheumatology society lupus registry cohort

Lupus science & medicine, 2020-03, Vol.7 (Suppl 1), p.A102

2020

Volltextzugriff (PDF)

Asociación entre títulos de anticuerpos antinucleares y conectivopatías sistémicas en una Unidad de Reumatología

Reumatología clinica, 2017-05, Vol.13 (3), p.150-155

2017

Volltextzugriff (PDF)

Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain

Reumatología clinica (Barcelona), 2016-09, Vol.12 (5), p.256-262

2016

Volltextzugriff (PDF)

Association Between Antinuclear Antibodies Titers and Connective Tissue Diseases in a Rheumatology Department

Reumatología clinica (Barcelona), 2017-05, Vol.13 (3), p.150-155

2017

Volltextzugriff (PDF)

1 – 25 von 39

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(39)

Sprache

Erscheinungsjahr

n.n

Thema

Rheumatology
(26)
Life Sciences & Biomedicine
(22)
Science & Technology
(22)
Humans
(20)
Female
(18)
Male
(14)
Middle Aged
(13)
Adult
(12)
Cross-Sectional Studies
(8)
Aged
(7)
Lupus Erythematosus, Systemic - Complications
(7)
Prospective Studies
(7)
Retrospective Studies
(7)
Risk Factors
(7)
Systemic Lupus Erythematosus
(7)
Lupus
(6)
Patients
(6)
Rheumatoid Arthritis
(5)
Diabetes Mellitus
(4)
Lupus Erythematosus, Systemic - Drug Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort

Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain

Association between antinuclear antibody titers and connective tissue diseases in a Rheumatology Department

Does remission in systemic lupus erythematosus according to the 2021 DORIS definition match the treating rheumatologist's judgement?

Antiphospholipid syndrome (APS) in patients with systemic lupus erythematosus (SLE) implies a more severe disease with more damage accrual and higher mortality

Relevance of gastrointestinal manifestations in a large Spanish cohort of patients with systemic lupus erythematosus: what do we know?

Central nervous system involvement in systemic lupus erythematosus: Data from the Spanish Society of Rheumatology Lupus Register (RELESSER)

Antimalarials exert a cardioprotective effect in lupus patients: Insights from the Spanish Society of Rheumatology Lupus Register (RELESSER) analysis of factors associated with heart failure

SLESIS-R: an improved score for prediction of serious infection in patients with systemic lupus erythematosus based on the RELESSER prospective cohort

P129 Does the perspective of SLE patients match the expert opinion and definitions of remission and low disease activity state? Prospective analysis of 500 patients from a Spanish multicenter cohort

Steroid therapy in clinically stable but serologically active systemic lupus erythematosus prevents severe disease flares

68 years old woman with right leg weakness and colostasis

Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project

Diffuse alveolar hemorrhage in patients with systemic lupus erythematosus: data from the Spanish society of rheumathology Lupus Register (RELESSER)

Riociguat treatment in patients with pulmonary arterial hypertension: Final safety data from the EXPERT registry

Fibromyalgia prevalence and related factors in a large registry of patients with systemic lupus erythematosus

Vitamin D deficiency in chronic inflammatory rheumatic diseases: results of the cardiovascular in rheumatology [CARMA] study

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis

Lipoprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project

Use of risk chart algorithms for the identification of psoriatic arthritis patients at high risk for cardiovascular disease: findings derived from the project CARMA cohort after a 7.5-year follow-up period

Health Related Quality of Life in Rheumatoid Arthritis, Osteoarthritis, Diabetes Mellitus, End Stage Renal Disease and Geriatric Subjects. Experience From a General Hospital in Mexico

P149 Association between geographic and climatological conditions and cutaneous manifestations in lupus patients from the Spanish rheumatology society lupus registry cohort

Asociación entre títulos de anticuerpos antinucleares y conectivopatías sistémicas en una Unidad de Reumatología

Association of anti-Ro52, anti-Ro60 and anti-La antibodies with diagnostic, clinical and laboratory features in a referral hospital in Jerez, Spain

Association Between Antinuclear Antibodies Titers and Connective Tissue Diseases in a Rheumatology Department

Suchergebnisse filtern